Ucsf-Comprehensive Cancer Center

San Francisco, California 94158

1 studies enrolling now · 167 studies all time

What they study most

Acute Lymphocytic Leukemia, Adenocarcinoma, Adult Lymphoblastic Lymphoma, Anal Cancer, Anemia, B-Cell Acute Lymphoblastic Leukemia, Adult, Bladder Cancer, Bladder Neoplasms, Brain Tumor, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia

Studies at this site

• A Study of ZW251 in Participants With Advanced Solid Tumors — Recruiting now
• N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma — Completed
• N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation — Completed
• Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma — Running, not enrolling
• Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer — Completed
• S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma — Stopped early
• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer — Completed
• Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer — Completed
• Melatonin and Radiation Therapy in Treating Patients With Brain Metastases — Completed
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
• Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer — Completed
• Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer — Withdrawn before enrolling
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma — Completed
• Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma — Completed
• Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy — Completed
• Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer — Completed
• Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) — Stopped early
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma — Completed
• Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme — Stopped early
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — Completed
• Symptom Management After Breast Cancer Surgery — Completed
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma — Completed
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma — Completed
• Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma — Completed
• Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma — Completed
• Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors — Completed
• CCI-779 in Treating Patients With Malignant Glioma — Completed
• Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma — Completed
• FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
• Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma — Completed
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer — Completed
• Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery — Completed
• Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer — Completed
• Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer — Completed
• Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children — Completed
• Surgery in Treating Children With Neuroblastoma — Completed
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer — Completed
• Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery — Completed
• Positron Emission Tomography in Determining Stage of Esophageal Cancer — Completed
• Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
• Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord — Completed
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer — Completed